ASTEC LIFESCIENCES LTD
ASTEC · General/Diversified · NSE
₹741
Current Market Price
Fair Value (DCF)
₹242
Margin of Safety
-67.4%
Updated 8h ago
YieldIQ Score
6/100
Piotroski F-Score
1/9
Economic Moat
None
Confidence
0%
ROE
—
Debt/Equity
0.89
WACC
11.1%
Market Cap
₹1,651 Cr
Quality & Valuation
Neutral model outputs — no recommendations.
ROCE
—
Return on capital employed
EV / EBITDA
—
Enterprise multiple
Debt / EBITDA
—
Leverage vs earnings
Interest Coverage
-2.9×
EBIT covers interest
Current Ratio
0.93×
Short-term liquidity
Asset Turnover
0.43×
Revenue per ₹ of assets
Revenue CAGR (3Y)
-17.4%
3-year revenue growth
Revenue CAGR (5Y)
—
5-year revenue growth
DCF Scenario Analysis
vs CMP ₹740.8
Bear case
₹0
MoS -Infinity%
Base case
₹241.78
MoS -206.4%
Bull case
₹253.87
MoS -191.8%
Ratio Trends
ASTEC · last 8 annual periods
ROE
-57.3%
ROCE
-7.7%
Operating Margin
—
Debt / Equity
2.36×
PE
43.5×
EV / EBITDA
38.5×
Historical Financials
ASTEC · Annual, last 5 years· amounts in ₹Cr unless noted
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 | CAGR |
|---|---|---|---|---|---|---|
| Revenue | ₹555 Cr | ₹677 Cr | ₹127 Cr | ₹154 Cr | ₹381 Cr | -9.0% |
| EBITDA | — | ₹164 Cr | ₹88.8 Cr | ₹-0.6 Cr | ₹-61.0 Cr | — |
| EBIT | ₹93.8 Cr | ₹130 Cr | ₹0.2 Cr | ₹5.7 Cr | — | -50.2% |
| PAT | ₹65.1 Cr | ₹89.9 Cr | ₹-5.0 Cr | ₹-1.0 Cr | ₹-135 Cr | — |
| EPS (diluted) | ₹33.21 | ₹45.85 | ₹-2.54 | ₹0.50 | — | -65.0% |
| CFO | ₹-8.2 Cr | ₹23.6 Cr | ₹74.7 Cr | ₹10.2 Cr | ₹-8.4 Cr | — |
| CapEx | — | — | — | — | ₹-21.8 Cr | — |
| FCF | — | — | — | — | ₹-30.2 Cr | — |
| Total Assets | — | ₹897 Cr | ₹979 Cr | ₹975 Cr | ₹881 Cr | -0.4% |
| Total Debt | — | — | ₹330 Cr | ₹295 Cr | ₹555 Cr | +13.8% |
| Shareholders' Equity | — | — | ₹419 Cr | ₹369 Cr | ₹235 Cr | -13.5% |
CAGR computed across the visible window. Signs reverse if start value is zero or negative.
Peer Comparison
ASTEC vs 5 closest peers by market-cap band
| Peer | MoS | Score | Verdict | ROE | PE |
|---|---|---|---|---|---|
| SPIC SPIC | — | — | Pending | 13.0% | — |
| IPL IPL | — | — | Pending | 9.1% | — |
| MOL MOL | — | — | Pending | -0.7% | — |
| GSPCROP GSPCROP | — | — | Pending | 18.5% | — |
| INSECTICID INSECTICID | — | — | Pending | 13.1% | — |
Click a ticker to view its fair-value analysis.
Dividend History
No dividend events recorded for ASTEC in the last 10 years.
Reverse DCF
Market-implied growth
What FCF growth is priced in →
Risk Analysis
Volatility & drawdown
Risk profile of ASTEC →
DuPont
ROE decomposition
Why ROE is what it is →
Technicals
RSI, MACD, MAs
Reference indicators →
News & Filings
Recent activity
BSE filings + news for ASTEC →
Compare
Head-to-head with peers
Compare ASTEC side by side →
Run Full Interactive Analysis
Interactive DCF sliders, sensitivity heatmap, peer comparison, and more.
Analyse ASTECNow →Model estimates using publicly available data. Not investment advice. YieldIQ is not registered with SEBI as an investment adviser or research analyst. Past performance does not guarantee future results.